Please Wait.....
Report
Global Markets for Insulin Drug and Delivery Technologies
Market Research Report I 2022-08-19 I 120 Pages I BCC Research
Description
Report Scope:
The current report will provide an in-depth look at the insulin drug and delivery technologies market. This report analyzes the market trends of insulin drug and delivery technologies with data from 2021, estimates from 2022, projections of compound annual growth rates through 2027 (forecast period 2022-2027), and regional markets of the insulin drug and delivery technologies. This report will highlight the current and future market potential of insulin drug and delivery technologies along with a detailed analysis of the competitive environment. Regulatory scenarios, drivers, restraints and opportunities will be covered in the current report. The report also covers market projections for 2026 and market share for key market players.
In this report, the market has been segmented based on device type, insulin type and geographic region. Device types include syringes, insulin pens, insulin pumps, smart pens and others. Insulin types include long-acting, rapid-acting, premixed insulins, intermediate-acting and short-acting.
Geographic regions covered include North America, Europe, Asia-Pacific and the rest of the world (RoW). Individual countries covered include the U.S., Germany, the U.K., Italy, France, Japan, China and India.
Report Includes:
- 24 data tables and 31 additional tables
- An up-to-date review of the global markets for insulin drug and delivery technologies
- Analyses of the global market trends, with historic market revenue (sales data) for 2020 and 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
- Highlights of the current state of the insulin drug and delivery industry structure, novel technological updates and issues surrounding insulin pens and insulin syringes, ongoing research activities, and regulatory and pricing scenarios
- Estimation of the actual market size and market forecast for insulin drug and delivery technologies, and corresponding market share analysis by device type, insulin type, and geographic region
- Updated information on the key merger and acquisition deals, partnerships, collaborations and other strategic alliances within the insulin drug and delivery technologies industry
- Analysis of market opportunities with a holistic review of the Porter's Five Forces analysis model considering both the micro and macro environmental factors prevailing in the market
- Identification of the major stakeholders and analysis of the competitive landscape based on recent developments and segmental revenues
- Descriptive company profiles of key manufacturers of modern insulin and insulin delivery devices, including Sanofi, Eli Lilly, Novo Nordisk, Medtronic, F. Hoffmann-La Roche (Roche) Ltd., Becton Dickinson (BD), Ypsomed AG and B. Braun Melsungen AG
Executive Summary
Summary:
Insulin drug and delivery technologies are used to manage type 1 and type 2 diabetes. Expedient insulin delivery devices such as smart pens help diabetes patients optimize blood glucose control and minimize the risk of associated health issues. Advanced insulin delivery devices offer better patient conformity.
The traditional syringes and insulin pumps are being replaced by reusable and disposable insulin pens due to the latter's portability, greater dosage accuracy, built-in memory, larger dosages and ease of use. There have been no major breakthrough in traditional syringes and pumps.
Major makers of insulin delivery devices include Medtronic, F. Hoffmann-La Roche (Roche) Ltd., Becton Dickinson (BD), Ypsomed AG and B. Braun Melsungen AG. Key manufacturers of modern insulin and human insulin include Sanofi, Eli Lilly, Novo Nordisk, Boehringer Ingelheim International GmbH, Biocon and Viatris Inc.
The global market for insulin drug and delivery technologies was valued at $REDACTED in 2021. The market is expected to grow at a compound annual growth rate (CAGR) of REDACTED% to reach over $REDACTED by the end of 2027. Market growth is attributed to factors such as the increasing incidence of diabetes and novel insulin drug and delivery technologies. The global market for insulin drug and delivery technologies is segmented by device type, insulin type and region.
Table of Contents
Chapter 1 Introduction
1.1 Insulin Overview
1.2 Diabetes Overview
1.2.1 Disease Symptoms and Risk Factors
1.2.2 Epidemiology and Economic Burden
1.3 Study Goals and Objectives
1.4 Reasons for Doing this Study
1.5 What's New in this Update?
1.6 Scope of Report
1.7 Information Sources
1.8 Methodology
1.9 Geographic Breakdown
1.10 Analyst's Credentials
1.11 BCC Custom Research
1.12 Related BCC Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Market Dynamics
3.1 Market Drivers
3.1.1 Rising Prevalence of Diabetes
3.1.2 Smart Insulin Drug Delivery Technologies
3.1.3 Painless Insulin Drug Delivery Technologies
3.2 Market Restraints
3.2.1 Product Recalls
3.3 Market Opportunities
3.3.1 Inorganic Strategies amongst Market Players
Chapter 4 Market Overview
4.1 Market Insights
4.1.1 Insulin
4.1.2 Diabetes
4.2 Current Market Trends
4.2.1 Recent Product Introductions
4.2.2 Recent Strategic Alliances
4.3 Future Perspective
Chapter 5 Regulatory Landscape and Reimbursement Scenario
5.1 Regulatory Landscape
5.1.1 U.S. Regulations for Medical Devices
5.1.2 U.S. Drug Regulations
5.1.3 European Regulations for Medical Devices
5.1.4 European Regulations for Drugs
5.1.5 Asia-Pacific Regulations for Medical Devices
5.2 Reimbursement Scenario
5.2.1 Pricing and Reimbursement Overview
5.2.2 Pricing and Reimbursement for Medical Devices
5.2.3 Pricing and Reimbursement for Pharmaceuticals
5.3 Insurance
5.3.1 Insurance for Diabetic Emergencies
Chapter 6 Impact of COVID-19 on Market
6.1 Overview
6.2 COVID-19 Crisis
6.2.1 Impact on Market for Insulin Drug and Delivery Technologies
6.2.2 COVID-19 Measures
Chapter 7 Market Breakdown by Device Type
7.1 Insulin Delivery Technologies
7.1.1 Syringes
7.1.2 Insulin Pens
7.1.3 Insulin Pumps
7.1.4 Smart Pens
7.1.5 Others
Chapter 8 Market Breakdown by Insulin Type
8.1 Insulin
8.1.1 Structure of Insulin
8.1.2 Insulin Biosynthesis
8.1.3 Insulin Types
Chapter 9 Market Breakdown by Region
9.1 Overview
9.1.1 North America
9.1.2 Europe
9.1.3 Asia-Pacific
9.1.4 Rest of the World
Chapter 10 Analysis of Market Opportunities
10.1 Porter's Five Forces Analysis
10.1.1 Threat of New Entrants
10.1.2 Threat of Substitutes
10.1.3 Bargaining Power of Suppliers
10.1.4 Bargaining Power of Buyers
10.1.5 Degree of Competition
Chapter 11 Competitive Landscape
Chapter 12 Company Profiles
12.1 Major Companies
B. BRAUN MELSUNGEN AG
BECTON, DICKINSON AND CO.
BIOCON
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
ELI LILLY AND CO.
F. HOFFMANN-LA ROCHE LTD.
MEDTRONIC INC.
NOVO NORDISK A/S
SANOFI
VIATRIS INC.
YPSOMED HOLDING AG
Other Companies
CEQUR SIMPLICITY
DEBIOTECH SA
EMPERRA GMBH E-HEALTH TECHNOLOGIES
INSULET CORP.
NANOPASS TECHNOLOGIES LTD.
NIPRO MEDICAL CORP.
OWEN MUMFORD LTD.
TANDEM DIABETES CARE INC.
Chapter 13 Appendix: Acronyms
List of Tables
Summary Table : Global Market for Insulin Drug and Delivery Technologies, by Device Type, Through 2027
Table 1 : Cases of Diabetes Worldwide, by Type
Table 2 : Global Prevalence of Diabetes, by Type, Through 2040
Table 3 : Global Diabetes Estimates and Projections, 2019-2045
Table 4 : History of Insulin Isolation and Development
Table 5 : Currently Available Insulin Brands
Table 6 : Features of Type 1 and Type 2 Diabetes
Table 7 : Strategic Alliances in the Market for Insulin Drug and Delivery Technologies, 2020-2022
Table 8 : Insulin Drug and Delivery Technologies Pipeline
Table 9 : Global Market for Insulin Drug and Delivery Technologies, by Device Type, Through 2027
Table 10 : Advantages and Disadvantages of Syringes
Table 11 : Global Market for Syringe Delivery Technologies, by Region, Through 2027
Table 12 : Advantages and Disadvantages of Insulin Pens
Table 13 : Global Market for Insulin Pen Delivery Technologies, by Region, Through 2027
Table 14 : Advantages and Disadvantages of Insulin Pumps
Table 15 : Global Market for Insulin Pump Delivery Technologies, by Region, Through 2027
Table 16 : Global Market for Smart Insulin Pen Delivery Technologies, by Region, Through 2027
Table 17 : Global Market for Other Types of Delivery Technologies, by Region, Through 2027
Table 18 : Advantages and Disadvantages of Various Insulin Delivery Systems
Table 19 : Types of Insulin and Their Features
Table 20 : Global Market for Insulin Drug and Delivery Technologies, by Insulin Type, Through 2027
Table 21 : Global Market for Long-acting Insulin, by Region, Through 2027
Table 22 : Global Market for Rapid-acting Insulin, by Region, Through 2027
Table 23 : Global Market for Intermediate-acting Insulin, by Region, Through 2027
Table 24 : Global Market for Short-acting Insulin, by Region, Through 2027
Table 25 : Global Market for Premixed Insulin, by Region, Through 2027
Table 26 : Global Market for Insulin Drug and Delivery Technologies, by Region, Through 2027
Table 27 : Diabetes Estimates in North America, by Country, 2000-2045
Table 28 : North American Market for Insulin Drug and Delivery Technologies, by Country, Through 2027
Table 29 : Diabetes Estimates in Europe, by Country, 2000-2045
Table 30 : European Market for Insulin Drug and Delivery Technologies, by Country, Through 2027
Table 31 : Diabetes Estimates for the Asia-Pacific Region, by Country, 2000-2045
Table 32 : Asia-Pacific Market for Insulin Drug and Delivery Technologies, by Country, Through 2027
Table 33 : Diabetes Estimates in the RoW, by Country, 2000-2045
Table 34 : Porter's Five Forces Analysis: Insulin Drug and Delivery Technologies Market
Table 35 : B. Braun Melsungen: Insulin Drug and Delivery Product Portfolio
Table 36 : BD: Insulin Drug and Delivery Product Portfolio
Table 37 : Biocon: Insulin Product Portfolio
Table 38 : Biocon: Key Developments, 2020-2021
Table 39 : Boehringer Ingelheim: Insulin Product Portfolio
Table 40 : Eli Lilly: Insulin Products
Table 41 : Eli Lilly: Key Developments, 2020-2021
Table 42 : F. Hoffmann-La Roche: Insulin Drug and Delivery Product Portfolio
Table 43 : F. Hoffmann-La Roche: Key Developments, 2021
Table 44 : Medtronic: Insulin Drug and Delivery Products Portfolio
Table 45 : Medtronic: Key Developments, 2020-2021
Table 46 : Novo Nordisk: Insulin Drug and Delivery Products Portfolio
Table 47 : Novo Nordisk: Key Developments, 2018-2022
Table 48 : Sanofi: Insulin Drug and Delivery Products Portfolio
Table 49 : Sanofi: Key Developments, 2018-2021
Table 50 : Viatris: Insulin Drug and Delivery Products Portfolio
Table 51 : Viatris: Key Developments, 2021
Table 52 : Ypsomed Holding AG: Insulin Drug and Delivery Products Portfolio
Table 53 : Ypsomed Holding AG: Key Developments, 2020-2022
Table 54 : Acronyms Used in This Report
List of Figures
Figure A : Timeline of Major Insulin Breakthroughs
Summary Figure A : Global Insulin Drug and Delivery Technologies Market
Summary Figure B : Global Market Shares of Insulin Drug and Delivery Technologies, by Device Type, 2021
Figure 1 : Cases of Diabetes Worldwide, by Type
Figure 2 : Global Prevalence of Diabetes, by Type, 2018-2040
Figure 3 : Medical Device Marketing Process in the U.S.
Figure 4 : Global Market Shares of Insulin Delivery Technologies, 2021 and 2027
Figure 5 : Global Market for Syringes Delivery Technologies, 2020-2027
Figure 6 : Global Market for Insulin Pen Delivery Technologies, 2020-2027
Figure 7 : Global Market for Insulin Pump Delivery Technologies, 2020-2027
Figure 8 : Global Market for Smart Insulin Pen Delivery Technologies, 2020-2027
Figure 9 : Global Market for Other Types of Delivery Technologies, 2020-2027
Figure 10 : Global Market Shares of Insulin Drug and Delivery Technologies, by Insulin Type, 2021 and 2027
Figure 11 : Global Market for Long-acting Insulin, 2020-2027
Figure 12 : Global Market for Rapid-acting Insulin, 2020-2027
Figure 13 : Global Market for Intermediate-acting Insulin, 2021-2027
Figure 14 : Global Market for Short-acting Insulin, 2020-2027
Figure 15 : Global Market for Premixed Insulin, 2020-2027
Figure 16 : Snapshot of Global Market for Insulin Drug and Delivery Technologies, 2021
Figure 17 : Global Market Shares of Insulin Drug and Delivery Technologies, by Region, 2021
Figure 18 : Snapshot of North American Market for Insulin Drug and Delivery Technologies, 2021
Figure 19 : North American Market for Insulin Drug and Delivery Technologies, by Country, 2021-2027
Figure 20 : Snapshot of European Market for Insulin Drug and Delivery Technologies, 2021
Figure 21 : European Market for Insulin Drug and Delivery Technologies, by Country, 2020-2027
Figure 22 : European Market Shares of Insulin Drug and Delivery Technologies, by Country, 2021
Figure 23 : Snapshot of Asia-Pacific Market for Insulin Drug and Delivery Technologies, 2021
Figure 24 : Asia-Pacific Market for Insulin Drug and Delivery Technologies, by Country, 2021-2027
Figure 25 : Asia-Pacific Market Shares of Insulin Drug and Delivery Technologies, by Country, 2021
Figure 26 : Global Market Shares of Insulin Drug and Delivery Technologies, by Company, 2021
Figure 27 : B. Braun Melsungen: Annual Revenue, 2018-2021
Figure 28 : B. Braun Melsungen: Revenue Share, by Division, 2021
Figure 29 : BD: Annual Revenue, 2018-2021
Figure 30 : BD: Revenue Share, by Business Segment, 2021
Figure 31 : Boehringer Ingelheim: Annual Revenue, 2018-2021
Figure 32 : Boehringer Ingelheim: Revenue Share, by Business Segment, 2021
Figure 33 : Eli Lilly: Annual Revenue, 2018-2021
Figure 34 : F. Hoffmann-La Roche: Annual Revenue, 2018-2021
Figure 35 : F. Hoffmann-La Roche: Revenue Share, by Division, 2021
Figure 36 : Medtronic: Annual Revenue, 2018-2021
Figure 37 : Medtronic: Revenue Share, by Business Segment, 2021
Figure 38 : Novo Nordisk: Annual Revenue, 2018-2021
Figure 39 : Novo Nordisk: Revenue Share, by Business Segment, 2021
Figure 40 : Sanofi: Annual Revenue, 2018-2021
Figure 41 : Sanofi: Revenue Share, by Business Unit, 2021
Figure 42 : Viatris: Annual Revenue, 2018-2021
Figure 43 : Viatris: Revenue Share, by Product Category, 2020
Figure 44 : Ypsomed Holding AG: Annual Revenue, 2018-2021
Figure 45 : Ypsomed Holding AG: Revenue Share, by Business Unit, 2021
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security